BIOTECH

BIOTECH

KAHR Bio Announces Strong Topline Phase 2 Results for DSP107 in Combination with Anti-PD-L1 Therapy in Colorectal Cancer

Phase 2 data demonstrated 17.5-month median overall survival in advanced, chemo-refractory patients with microsatellite stable...

Read more

BIOTECH

Lattice Medical raises €43 million to transform post-cancer reconstruction

Lille, France, October 23, 2025 – LATTICE MEDICAL, a French Medtech company specializing in tissue...

Read more

BIOTECH

TREOS Bio Partners with Charité Berlin and Junshi Biosciences to Launch Pivotal Phase II Clinical Trial in Refractory MSS Colorectal Cancer

LONDON, Aug. 27, 2025 (GLOBE NEWSWIRE) — TREOS Bio Ltd., a clinical-stage biotechnology company developing...

Read more

BIOTECH

Vaxxas secures ~A$90 million in funding to commercialise needle-free vaccination delivery technology

BRISBANE, Australia, Aug. 25, 2025 (GLOBE NEWSWIRE) — Vaxxas Pty Ltd, the biotechnology company pioneering...

Read more

BIOTECH

Doron Therapeutics Announces Positive End-of-Phase 2 and Initial RMAT Meeting With FDA for MOTYS (PTP-001) in the Treatment of Knee Osteoarthritis

CHAPEL HILL, NORTH CAROLINA / ACCESS Newswire / May 20, 2025 / Doron Therapeutics, a clinical-stage biotechnology company...

Read more